Endoscope to Identify A Smoker's Oral Mucosa for Early Obstructive Airway Disease Detection
Abstract
Background: The synergistic association between oral cavity disorders and airway disorders in smokers has long been recognized. Periodontal disease and airway obstruction are 20 times more likely in smokers. Smoking causes increased inflammatory cytokines in the oral mucosa; generally, airway obstruction has been associated with increased inflammatory markers in the airway mucosa. This study developed a prototype to visualize smokers' oral mucosa to identify potential airway obstruction disease.
Methods: This study collected many types of oral mucosal lesions that are typically found in smokers, such as leukoplakia, nicotinic stomatitis, black hairy tongue, oral cancer, and smoker melanosis, from various literature and images of the mucosa of patients with a history of smoking who were treated at the hospital. The data is divided into a training, validation, and testing set and then using the PyTorch framework and the UltraLytics library.
Results: This study created a prototype of an endoscope that can detect lesions on the oral mucosa-related airway obstruction disease. Sixty-three percent of the respondents who underwent prototype testing were between the ages of twenty-one and thirty. Of those who smoked, 86% had done so for five to ten years. Sixty percent of the respondents had no COPD diagnosis. The sensitivity of the prototype demonstrated a high rate of 84%. However, the specificity exhibited 57.14%.
Conclusion: Endoscopic detection of the oral mucosa can be used for early screening of suspected obstructive airway disorders in smokers. This tool could enhance screening for smoking's effects on the mouth and prevent early obstructive airway diseases.
Keywords
Full Text:
PDFReferences
World Health Organization. Chronic obstructive pulmonary disease (COPD) [Internet]. World Health Organization. 2022 [cited 2023 Mar 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
Harris RE. Epidemiology of chronic respiratory, metabolic, and musculoskeletal diseases: Epidemiology of chronic obstructive pulmonary disease. In: Harris RE, editor. Epidemiology of chronic disease : Global perspectives. 2nd ed. Burlington, MA: Jones & Bartlett Learning; 2020. p. 539–52.
Ji J, Von Schéele I, Bergström J, Billing B, Dahlén B, Lantz AS, et al. Compartment differences of inflammatory activity in chronic obstructive pulmonary disease. Respiratory Research. 2014;15:104.
Takeuchi K, Matsumoto K, Furuta M, Fukuyama S, Takeshita T, Ogata H, et al. Periodontitis is associated with chronic obstructive pulmonary disease. J Dent Res. 2019;98(5):534–40.
Xiong K, Yang P, Cui Y, Li J, Li Y, Tang B. Research on the association between periodontitis and COPD. International Journal of COPD. 2023;18:1937–48.
Wang X, Zhang D, Higham A, Wolosianka S, Gai X, Zhou L, et al. ADAM15 expression is increased in lung CD8+T cells, macrophages, and bronchial epithelial cells in patients with COPD and is inversely related to airflow obstruction. Respir Res. 2020;21(1):188.
Mortazavi H, Safi Y, Baharvand M, Jafari S, Anbari F, Rahmani S. Oral white lesions: An updated clinical diagnostic decision tree. Dentistry Journal. 2019;7: 15.
Mustapha AD, Salame Z, Chrcanovic BR. Smoking and dental implants: A systematic review and meta-analysis. Medicina (Lithuania). 2022;58:39.
Rodrigues S de O, da Cunha CMC, Soares GMV, Silva PL, Silva AR, Gonçalves-De-albuquerque CF. Mechanisms, pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease. Pharmaceuticals. 2021;14:979.
Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, et al. Definition and nomenclature of chronic obstructive pulmonary disease time for its revision. Am J Respir Crit Care Med. 2022;206(11):1317–25.
Lim R, Smith T, Usherwood T. Barriers to spirometry in Australian general practice: A systematic review. Aust J Gen Pract. 2023;52(9):585–93.
Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global initiative for chronic obstructive lung disease 2023 Report: GOLD executive summary. European Respiratory Journal. 2023;61(4):2300239.
Lin CH, Cheng SL, Chen CZ, Chen CH, Lin SH, Wang HC. Current progress of COPD early detection: Key points and novel strategies. Vol. 18, International Journal of COPD. 2023;18:1511–24.
Robertson NM, Centner CS, Siddharthan T. Integrating artificial intelligence in the diagnosis of COPD globally: A way forward. Chronic Obstructive Pulmonary Diseases. 2024;11(1):114–20.
Tang LYW, Coxson HO, Lam S, Leipsic J, Tam RC, Sin DD. Towards large-scale case-finding: training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT. Lancet Digit Health. 2020;2(5):e259–67.
Sheth KR, White JT, Perez-Orozco AF, Debolske ND, Hyde CR, Geistkemper C, et al. Evaluating natural history and follow up strategies for non-obstructive urolithiasis in pediatric population. Front Pediatr. 2018;6:353.
Sharma O. Deep challenges associated with deep learning. In: Proceedings of the International Conference on Machine Learning, Big Data, Cloud and Parallel Computing: Trends, Prespectives and Prospects, COMITCon 2019. 2019:72–5.
Sun C, Shrivastava A, Singh S, Gupta A. Revisiting unreasonable effectiveness of data in deep learning era. In: Proceedings of the IEEE International Conference on Computer Vision. 2017:843–52.
DOI: https://doi.org/10.36497/jri.v44i3.640
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Budi Yanti, Zarfan Fawwaz Muhamad, Teuku Fais Duta, Muhammad Iqbal Maulana, Irmayani, Yuli Fatzia Ossa, Sherina
INDEXING & PARTNER
Jurnal Respirologi Indonesia pISSN: 0853-7704 - eISSN: 2620-3162 Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia Phone: +62-21-2247-4845 Email: editor@jurnalrespirologi.org | An official publication by the Indonesian Society of Respirology (ISR) |
Creative Commons Attribution-ShareAlike 4.0 International License Statcounter |